Skip to main content

Table 4 Mean healthcare cost per exacerbation in the 30 days after an exacerbation (US database only)

From: The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

  

Total all-cause ($)

Total asthma-related ($)

  

mean (SD)

mean (SD)

Overall

 

1,368 (3,797)

520 (981)

GINA Step

Step 1

1,265 (3,981)

446 (908)

Step 2

1,376 (3,978)

465 (874)

Step 3

1,253 (3,242)

433 (782)

Step 4

1,425 (3,817)

516 (828)

Step 5

1,814 (3,614)

902 (1,533)

Not classifiable/none

946 (1,628)

332 (377)

Exacerbations during the 12-month pre-index period

<2

1,344 (3,836)

477 (861)

≥2

1,534 (3,516)

754 (1,451)

Severe uncontrolled asthmaa

Yes

1,692 (3,233)

911 (1,563)

No

1,347 (3,831)

486 (905)

Severe uncontrolled eosinophilic asthmab

Yes

2,040 (3,285)

1,073 (1,958)

No

1,692 (3,934)

615 (1,248)

  1. aDefined as patients at GINA Step 4 or 5 with ≥2 exacerbations in the previous 12 months; bpatients with severe uncontrolled asthma criteria and blood eosinophil counts ≥300 cells/μl at baseline
  2. GINA Global Initiative for Asthma, SD standard deviation